Colitis, Ulcerative: all 1,530 studies

Page 7 of 16. Open to participants first (407), then studies with results posted, then the rest; newest registration first within each.

• Predicting Response to Standardized Pediatric Colitis TherapyCompletedNCT01536535Phase 4Results posted
• Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA)CompletedNCT01532648Phase 3Results posted
• Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing ColonoscopyCompletedNCT01520324Phase 2Results posted
• Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative ColitisCompletedNCT01506362Phase 2Results posted
• The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis PatientsCompletedNCT01493960Phase 3Results posted
• Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative ColitisCompletedNCT01482884Phase 2Results posted
• Long-Term Study Of CP-690,550 In Subjects With Ulcerative ColitisCompletedNCT01470612Phase 3Results posted
• A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01465763Phase 3Results posted
• A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative ColitisCompletedNCT01458951Phase 3Results posted
• A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative ColitisCompletedNCT01458574Phase 3Results posted
• A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative ColitisCompletedNCT01456052Phase 2Results posted
• Mucosal Immunity of Ulcerative Colitis Patients Undergoing Therapy With Trichuris Suis OvaCompletedNCT01433471Not applicableResults posted
• Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative ColitisCompletedNCT01393405Phase 2Results posted
• Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsCompletedNCT01387594Phase 1Results posted
• Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)CompletedNCT01340872Phase 3Results posted
• Oral OKT3 for the Treatment of Active Ulcerative ColitisCompletedNCT01287195Phase 1/2Results posted
• Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis PatientsCompletedNCT01284062Phase 2Results posted
• A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative ColitisCompletedNCT01240915Phase 2Results posted
• Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative ColitisCompletedNCT01177228Phase 2Results posted
• Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative ColitisCompletedNCT01171807Phase 2Results posted
• Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative ColitisCompletedNCT01130844Phase 1Results posted
• Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative ColitisCompletedNCT01124149Phase 4Results posted
• (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release TabletsCompletedNCT01100112Phase 3Results posted
• Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI DisordersCompletedNCT01099111Results posted
• Effects of Carrageenan-Elimination Diet on Ulcerative Colitis Disease ActivityCompletedNCT01065571Not applicableResults posted
• Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative ColitisCompletedNCT01059344Phase 3Results posted
• Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative ColitisCompletedNCT01036022Phase 2Results posted
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents for the Maintenance of Remission of Ulcerative ColitisTerminatedNCT01004185Phase 3Results posted
• An Evaluation of SprayShield in Reducing Post-Operative Adhesion Formation Following Major Open Abdominal SurgeryTerminatedNCT01002287Not applicableResults posted
• Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)TerminatedNCT00984568Phase 3Results posted
• Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel DiseasesCompletedNCT00940576Not applicableResults posted
• A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00853099Phase 3Results posted
• The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative ColitisTerminatedNCT00805285Phase 2Results posted
• (CB-01-02/04) Extension Study of Budesonide Multi-Matrix System (MMX) 6 mg in Maintenance Of Remission In Patients With Ulcerative Colitis.CompletedNCT00801723Phase 3Results posted
• An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00790933Phase 3Results posted
• Melatonin and Ulcerative Colitis: A Pilot Clinical TrialTerminatedNCT00790478Phase 2Results posted
• A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.CompletedNCT00787202Phase 2Results posted
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative ColitisCompletedNCT00783718Phase 3Results posted
• Vaccines and Dietary Oats in the Treatment of Ulcerative ColitisTerminatedNCT00751933Phase 2Results posted
• Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative ColitisTerminatedNCT00748410Phase 2Results posted
• Pilot Study of Green Tea Extract (Polyphenon E®)in Ulcerative ColitisCompletedNCT00718094Phase 2Results posted
• Assessing the Safety/Efficacy of Asacol® Given Every 12 Hours to Children and Adolescents With Active Ulcerative ColitisCompletedNCT00713310Phase 3Results posted
• European Safety Registry in Ulcerative Colitis (P04808)CompletedNCT00705484Results posted
• (CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisCompletedNCT00679432Phase 3Results posted
• (CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisCompletedNCT00679380Phase 3Results posted
• Phase II Study of HMPL-004 in Patients With Ulcerative ColitisCompletedNCT00659802Phase 2Results posted
• Dose Escalation and Remission (DEAR)CompletedNCT00652145Phase 4Results posted
• Vitamin D Levels in Children With IBDTerminatedNCT00621257Not applicableResults posted
• The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative ColitisCompletedNCT00620126Phase 3Results posted
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00619489Phase 2Results posted
• A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative ColitisCompletedNCT00616434Phase 2Results posted
• Canadian Active & Maintenance Modified Pentasa StudyCompletedNCT00603733Phase 3Results posted
• Safety and Efficacy of Asacol 4.8 g/Day Versus Asacol 2.4 g/Day (ASCEND I)CompletedNCT00577473Phase 3Results posted
• Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative ColitisCompletedNCT00573794Phase 3Results posted
• Hypnotherapy for Prevention of Relapse in Ulcerative Colitis: a Randomised, Single-blind, Controlled Clinical TrialTerminatedNCT00553163Not applicableResults posted
• Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)TerminatedNCT00537316Phase 3Results posted
• A Comparison of Once a Day Dose Compared to 2 Doses/DayCompletedNCT00505778Phase 3Results posted
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative ColitisTerminatedNCT00488774Phase 2/3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00488631Phase 3Results posted
• An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT00487539Phase 2/3Results posted
• Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis StudyCompletedNCT00486031Phase 3Results posted
• An Exploratory Study of Rebamipide in Patients With Active Ulcerative ColitisCompletedNCT00463151Phase 2Results posted
• Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)CompletedNCT00446849Phase 4Results posted
• A Study of Abatacept in Patients With Active Ulcerative ColitisCompletedNCT00410410Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT00408629Phase 3Results posted
• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative ColitisCompletedNCT00385736Phase 3Results posted
• Safety and Compliance of Taking Mesalamine Once a Day in Pediatric PatientsTerminatedNCT00349388Not applicableResults posted
• A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative ColitisCompletedNCT00336492Phase 3Results posted
• Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in RemissionCompletedNCT00326209Phase 3Results posted
• A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative ColitisTerminatedNCT00317356Phase 2Results posted
• Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative ColitisCompletedNCT00151892Phase 3Results posted
• Safety and Efficacy of Two Different Doses of Asacol in the Treatment of Moderately Active Ulcerative ColitisCompletedNCT00073021Phase 3Results posted
• A Trial of Rosiglitazone for Ulcerative ColitisCompletedNCT00065065Phase 2Results posted
• Interferon-beta1a (AVONEX) Treatment of Ulcerative ColitisCompletedNCT00048347Phase 2Results posted
• Incremental Value of Traditional Chinese Medicine Features in Two-Stage Pre-Endoscopic PredictionCompletedNCT07784114
• The Safety and Efficacy of Good Feeling Power® for IBD PatientsCompletedNCT07766733Not applicable
• Development and External Validation of a Machine Learning Model for Pre-Endoscopic Prediction of Montreal Disease Extent (E1/E2/E3) in Ulcerative Colitis Using Symptoms, Signs, and Laboratory Tests: A Multicenter Retrospective Observational StudyActive, not recruitingNCT07721987
• Effectiveness and Safety of Mirikizumab in Patients With Moderate-to-severe Ulcerative Colitis: a Real-life Retrospective Multicenter StudyCompletedNCT07695636
• Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable DiseasesActive, not recruitingNCT07694609
• Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel DiseaseCompletedNCT07694362Not applicable
• Can Vitamin D Replacement Correct Chronic Disease Anemia?CompletedNCT07673497Phase 4
• Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life in Patients With Inflammatory Bowel DiseaseCompletedNCT07656233Not applicable
• Study on Variation of Serum and Fecal Biomarkers After Treatment to Predict Mucosal Healing in Patients With Ulcerative ColitisTerminatedNCT07653750Not applicable
• Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Anti-TNF TherapyCompletedNCT07652840Not applicable
• Eating Disorders in Patients With IBDCompletedNCT07610694
• Validation of the Reliability and Validity of the New Endoscopic Scoring System for Ulcerative Colitis (CAT-DESIRE Score) and Verification of Its Clinical PracticabilityCompletedNCT07608198
• Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.CompletedNCT07564895
• Physical Activity and Fitness in Pediatric Inflammatory Bowel DiseaseActive, not recruitingNCT07484620Not applicable
• Effectiveness and Safety of Upadacitinib for Acute Severe Ulcerative ColitisCompletedNCT07472309
• An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative ColitisActive, not recruitingNCT07459686
• A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingCompletedNCT07421258
• Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing ColonoscopyCompletedNCT07419204
• The Association Between Interleukin-7 Receptor Gene Polymorphism and the Risk of Ulcerative ColitisCompletedNCT07398586Phase 4
• Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.CompletedNCT07380022Not applicable
• Effect of Rutin on Inflammation Pathways in Ulcerative Colitis PatientsCompletedNCT07370220Phase 2
• Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy ParticipantsActive, not recruitingNCT07350577Phase 1
• A Clinical Study on The Use of DL-endopeptidase-producing Probiotics as an Adjunctive Therapy for Inflammatory Bowel Disease.Active, not recruitingNCT07318753Not applicable
• LATA-IBD TRIAL a Controlled Feasibility Study for the Introduction of Transanal Minimally Invasive IPAA-Surgery. Evaluation of Operative Results and Bowel Function After Introducing Transanal IPAA-surgery to Replace Conventional Laparoscopic IPAA-surgery.CompletedNCT07278687
• VedAryo® (Vedolizumab) Effectiveness and Safety EvaluationCompletedNCT07273760
• The Association Between TNFSF4 Polymorphism and CDCompletedNCT07263464

← Colitis, Ulcerative overview